<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref13">
 <mixed-citation publication-type="journal" id="cit13">
  <name>
   <surname>Adedeji</surname>
   <given-names>A. O.</given-names>
  </name>; 
  <name>
   <surname>Singh</surname>
   <given-names>K.</given-names>
  </name>; 
  <name>
   <surname>Kassim</surname>
   <given-names>A.</given-names>
  </name>; 
  <name>
   <surname>Coleman</surname>
   <given-names>C. M.</given-names>
  </name>; 
  <name>
   <surname>Elliott</surname>
   <given-names>R.</given-names>
  </name>; 
  <name>
   <surname>Weiss</surname>
   <given-names>S. R.</given-names>
  </name>; 
  <name>
   <surname>Frieman</surname>
   <given-names>M. B.</given-names>
  </name>; 
  <name>
   <surname>Sarafianos</surname>
   <given-names>S. G.</given-names>
  </name>
  <article-title>Evaluation of SSYA10–001 as a replication inhibitor of severe acute respiratory syndrome, mouse hepatitis, and Middle East respiratory syndrome coronaviruses</article-title>. 
  <source>Antimicrob. Agents Chemother.</source>
  <year>2014</year>, 
  <volume>58</volume> (
  <issue>8</issue>), 
  <fpage>4894</fpage>–
  <lpage>8</lpage>. 
  <pub-id pub-id-type="doi">10.1128/AAC.02994-14</pub-id>.
  <pub-id pub-id-type="pmid">24841268</pub-id>
 </mixed-citation>
</ref>
